BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Hindustan Unilever Ltd.’s Q2 FY21 revenue was ahead of our estimate, but adjusted profit after tax was in line.
Core business registered 3% sales growth with 1% volume growth.
Foods and refreshment posted mere 60 basis points expansion in Ebit margin – was a muted performance.
Addition of GlaxoSmithKline Consumer Healthcare Ltd. portfolio is expected to enhance margins here on.
Small stock keeping units contribution has increased in rural areas while consumption of large packs has remained firm in urban geographies.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR